1. Home
2. Symposia (BVIKM)
3. Symposia
4. 48ste Symposium

48ste Symposium

PARENTERAL ANTIBIOTICS: FROM INTENSIVE TO HOME DOSING

• State of the art on PK-PD of betalactams.

  • What do we know on PK-PD of betalactams? [Françoise VAN BAMBEKE (UCL, Brussel)]
  • Optimization of the dosing of beta-lactams to prevent emergence of resistance. [Vincent TAM (University of Houston, Houston, Verenigde Staten)]
  • Increased dosing of betalactams = increased toxicity? [Marjorie Beumier (CHU Ambroise Paré, Bergen)]
  • Interactive questions on the clinical translation of recent PK-PD insights.
  • Intermittent infusion without TDM. [Deborah KONOPNICKI (UMC Sint-Pieter, Brussel)]
  • Intermittent infusion with TDM. [Patrick HONORE (UZ Brussel, Brussel)]
  • Prolonged infusion with TDM. [Maya HITES (Hôpital Erasme -ULB, Brussel)]
  • Prolonged infusion without TDM. [Jan DE WAELE (UZ Gent, Gent)]

• OPAT (outpatient parenteral antibiotic therapy).

  • OPAT: what is in a name? [Franky BUYLE (UZ Gent, Gent)]
  • Possible indictions for OPAT.  [Xavier HOLEMANS (Grand Hôpital de Charleroi, Charleroi]
  • OPAT: which antibiotics can be used? [Franky BUYLE (UZ Gent, Gent)]
  • Organisation of OPAT: international literature put into practice in Belgium. [Ester STEFFENS (UZ Leuven, Leuven)]
  • OPAT: a pilot project. [Dirk VOGELAERS (UZ Gent, Gent)]